Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 13/20 | 0.50 |
| ▸ | PPARD | Q03181 | 13/20 | 0.50 |
| ▸ | PPARA | Q07869 | 13/20 | 0.50 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.41 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.41 |
| ▸ | LTB4R | Q15722 | 5/20 | 0.38 |
| ▸ | LTB4R2 | Q9NPC1 | 5/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6559223 | 0.91 | PPARA (0.50) | PPARGPPARDPPARANR1H2NR1H3 | |
| SCHEMBL7043006 | 0.81 | PPARA (0.55) | PPARGPPARDPPARANR1H2NR1H3 | |
| SCHEMBL7043010 | 0.81 | PPARG (0.51) | PPARGPPARDPPARANR1H2NR1H3 | |
| SCHEMBL6560086 | 0.80 | PPARD (0.59) | PPARGPPARDPPARANR1H2NR1H3 | |
| SCHEMBL6561689 | 0.72 | PPARA (0.62) | PPARGPPARDPPARA | |
| SCHEMBL7040314 | 0.72 | PPARA (0.55) | PPARGPPARDPPARANR1H2NR1H3 | |
| SCHEMBL7040316 | 0.71 | PPARA (0.51) | PPARGPPARDPPARANR1H2NR1H3 | |
| SCHEMBL6559159 | 0.71 | PPARA (0.63) | PPARGPPARDPPARANR1H2NR1H3 | |
| SCHEMBL6560614 | 0.67 | PPARD (0.75) | PPARGPPARDPPARANR1H2NR1H3 | |
| SCHEMBL6559323 | 0.66 | PPARG (0.59) | PPARGPPARDPPARANR1H2NR1H3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0904079-B1 | ANTIDIABETIC AGENTS | MERCK & CO INC (US) | 2004-03-24 | — | — | EP | claimed |
| EP-0904079-A4 | — | — | 1999-05-06 | — | — | EP | claimed |
| EP-0904079-A1 | ANTIDIABETIC AGENTS | Merck & Co., Inc. (US) | 1999-03-31 | — | — | EP | claimed |
| WO-1997027857-A1 | ANTIDIABETIC AGENTS | MERCK & CO., INC. (US) | 1997-08-07 | — | — | WO | claimed |
| EP-0904079-B1 | ANTIDIABETIC AGENTS | MERCK & CO INC (US) | 2004-03-24 | — | — | EP | disclosed |
| EP-0904079-A4 | — | — | 1999-05-06 | — | — | EP | disclosed |
| EP-0904079-A1 | ANTIDIABETIC AGENTS | Merck & Co., Inc. (US) | 1999-03-31 | — | — | EP | disclosed |
| US-5859051-A | ACETYLPHENOL DERIVATIVES | MERCK & CO., INC. (US) | 1999-01-12 | — | — | US | disclosed |
| WO-1997027857-A1 | ANTIDIABETIC AGENTS | MERCK & CO., INC. (US) | 1997-08-07 | — | — | WO | disclosed |